Rein Therapeutics Inc.

RNTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 4, 2026 8-K
8-K Aug 27, 2026 8-K
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
10-Q Aug 14, 2026 10-Q
SCHEDULE 13G/A Aug 13, 2026
8-K Jul 21, 2026 8-K
SCHEDULE 13G/A Jul 14, 2026
ARS Jun 8, 2026 ARS
DEFA14A Jun 8, 2026 DEFA14A
DEF 14A Jun 8, 2026 DEF 14A
4 May 28, 2026 4
PRE 14A May 28, 2026 PRE 14A
10-Q May 15, 2026 10-Q
4 May 13, 2026 4
SCHEDULE 13G/A May 8, 2026
SCHEDULE 13G May 8, 2026
SCHEDULE 13G May 7, 2026
SCHEDULE 13G May 6, 2026
8-K May 4, 2026 8-K
424B5 May 4, 2026 424B5
EFFECT Apr 30, 2026
CORRESP Apr 28, 2026
CORRESP Apr 28, 2026
S-1 Apr 28, 2026 S-1
← Newer Page 1 of 21 · 525 filings Older →